Assessment of Resistomycin, As an Anticancer Compound Isolated and Characterized from Streptomyces Aurantiacus AAA5
Overview
Authors
Affiliations
A new actinomycete strain, isolated from humus soils in the Western Ghats, was found to be an efficient pigment producer. The strain, designated AAA5, was identified as a putative Streptomyces aurantiacus strain based on cultural properties, morphology, carbon source utilization, and analysis of the 16S rRNA gene. The strain produced a reddish-brown pigmented compound during the secondary metabolites phase. A yellow compound was derived from the extracted pigment and was identified as the quinone-related antibiotic resistomycin based on ultraviolet-visible spectrophotometry, fourier transform infrared spectroscopy, liquid chromatography and mass spectroscopy, and nuclear magnetic resonance analyses. The AAA5 strain was found to produce large quantities of resistomycin (52.5 mg/L). It showed potent cytotoxic activity against cell lines viz. HepG2 (hepatic carcinoma) and HeLa (cervical carcinoma) in vitro, with growth inhibition (GI(50)) of 0.006 and 0.005 μg/ml, respectively. The strain also exhibited broad antimicrobial activities against both Gram-positive and Gram-negative bacteria. Therefore, AAA5 may have great potential as an industrial resistomycin-producing strain.
Kanchanasin P, Salahong T, Sripreechasak P, Suriyachadkun C, Harunari E, Igarashi Y Sci Rep. 2024; 14(1):22140.
PMID: 39333582 PMC: 11436869. DOI: 10.1038/s41598-024-73040-4.
Islam A, Chang Y, Chen X, Weng C, Chen C, Wang C Elife. 2024; 12.
PMID: 38567911 PMC: 10990494. DOI: 10.7554/eLife.87873.
sp. nov., a chromomycin producing bacteria isolated from the roots of .
Chhetri G, Kim M, Kim I, Tran D, Kim Y, Kim H Front Microbiol. 2024; 15:1361583.
PMID: 38495511 PMC: 10940327. DOI: 10.3389/fmicb.2024.1361583.
Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents.
Giurini E, Godla A, Gupta K Cancer Gene Ther. 2024; 31(2):187-206.
PMID: 38200347 PMC: 10874892. DOI: 10.1038/s41417-023-00715-x.
Zhu Y, Zhang E, Gao H, Shang C, Yin M, Ma M Mar Drugs. 2023; 21(12).
PMID: 38132944 PMC: 10745072. DOI: 10.3390/md21120622.